IGF and IGF Receptor Function in Mammary Development

IGF 和 IGF 受体在乳腺发育中的功能

基本信息

  • 批准号:
    7671330
  • 负责人:
  • 金额:
    $ 29.93万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-03-01 至 2012-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The IGF ligands, IGF-I and IGF-II, and the IGF type I receptor (IGF-IR) have demonstrated roles in growth of mammary epithelium during normal development. Moreover, the IGFs and IGF-IR promote proliferation of breast cancer cells and are implicated in incidence and growth of breast cancers. Our previous studies demonstrated that IGF-I and IGF-II are distinctly expressed during pubertal and pregnancy-induced development of the mammary epithelium. During the previous funding period, we demonstrated that IGF-I regulates cell cycle progression in mammary epithelial cells and showed unique roles for IGF-I expressed in epithelial and stromal compartments of the developing mammary gland. We further elucidated how patterning of IGF-II expression is regulated in the mammary epithelium. Recent data suggest that the IGF ligands can signal through heterodimers of the IGF-IR and the insulin receptor (IR) in addition to homodimers of the IGF-IR. Moreover, a splice variant of the IR known as the IR-A isoform, has high specificity for IGF-II but not IGF-I. Our preliminary data show that mammary specific deletion of the IR during alveolar differentiation results in significant disruption of alveolar development and lactation. Furthermore, analysis of receptor expression suggests that the ratio of the two IR isoforms varies in mammary epithelial cells during pregnancy and lactation and that a significant portion of the IGF-IR exists as a hybrid receptor with the IR in mammary epithelial cells. Thus, the goal of the experiments proposed in this application is to test the hypothesis that the different IGF signaling receptors have distinct functions in alveolar differentiation and lactation. To test this hypothesis, we propose both in vitro experiments and in vivo transgenic studies to activate or disrupt signaling through the IRs, IGF-IR and hybrid receptors in mammary epithelial cells. Public Health Relevance Statement: The results of the proposed experiments will elucidate IGF receptor-specific actions and downstream signaling pathways in proliferation, survival and differentiation of normal mammary epithelial cells. These studies will also have important implications for the roles of these receptors and pathways in breast cancers.
描述(申请人提供):IGF配体,IGF-I和IGF-II,以及IGF-I型受体(IGF-IR)已被证明在正常发育的乳腺上皮生长中起作用。此外,IGFS和IGF-IR促进乳腺癌细胞的增殖,并与乳腺癌的发生和生长有关。我们以前的研究表明,IGF-I和IGF-II在青春期和妊娠诱导的乳腺上皮发育过程中有明显的表达。在之前的资助期间,我们证明了IGF-I调节乳腺上皮细胞的细胞周期进程,并证明了IGF-I在发育中的乳腺上皮和间质中表达的独特作用。我们进一步阐明了IGF-II的表达模式是如何在乳腺上皮中调节的。最近的数据表明,除了IGF-IR的同源二聚体外,IGF配体还可以通过IGF-IR和胰岛素受体(IR)的异源二聚体来传递信号。此外,IR的一个剪接变体被称为IR-A亚型,对IGF-II有高度的特异性,但对IGF-I没有。我们的初步数据显示,在肺泡分化过程中,乳腺特异的IR缺失会导致明显的肺泡发育和哺乳中断。此外,对受体表达的分析表明,在妊娠和哺乳期间,两种IR亚型在乳腺上皮细胞中的比例不同,很大一部分IGF-IR以杂交受体的形式存在于乳腺上皮细胞中。因此,在本申请中提出的实验的目的是检验不同的IGF信号受体在肺泡分化和哺乳中具有不同功能的假设。为了验证这一假设,我们提出了体外实验和体内转基因研究,以激活或破坏乳腺上皮细胞中IRS、IGF-IR和混合受体的信号传递。 公共卫生相关声明:拟议的实验结果将阐明IGF受体在正常乳腺上皮细胞增殖、存活和分化中的特定作用和下游信号通路。这些研究还将对这些受体和通路在乳腺癌中的作用产生重要影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Teresa L Wood其他文献

Teresa L Wood的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Teresa L Wood', 18)}}的其他基金

ASN Annual Meeting 2020
2020 年 ASN 年会
  • 批准号:
    10000613
  • 财政年份:
    2020
  • 资助金额:
    $ 29.93万
  • 项目类别:
Pathways that regulate basal and metastatic phenotypes in triple negative breast cancers
调节三阴性乳腺癌基础表型和转移表型的途径
  • 批准号:
    10059304
  • 财政年份:
    2017
  • 资助金额:
    $ 29.93万
  • 项目类别:
Pathways that regulate basal and metastatic phenotypes in triple negative breast cancers
调节三阴性乳腺癌基础表型和转移表型的途径
  • 批准号:
    9246896
  • 财政年份:
    2017
  • 资助金额:
    $ 29.93万
  • 项目类别:
2013, 2014 and 2015 Mammary Gland Biology Gordon Research Conference & Gordon Res
2013年、2014年和2015年乳腺生物学戈登研究会议
  • 批准号:
    8526013
  • 财政年份:
    2013
  • 资助金额:
    $ 29.93万
  • 项目类别:
IGF and IGF Receptor Function in Mammary Development
IGF 和 IGF 受体在乳腺发育中的功能
  • 批准号:
    8036817
  • 财政年份:
    2010
  • 资助金额:
    $ 29.93万
  • 项目类别:
Nestin: A Putative Marker of a Mammary Stem and Progenitor Cell Lineage
巢蛋白:乳腺干细胞和祖细胞谱系的假定标记
  • 批准号:
    7230129
  • 财政年份:
    2006
  • 资助金额:
    $ 29.93万
  • 项目类别:
Nestin: A Putative Marker of a Mammary Stem and Progenitor Cell Lineage
巢蛋白:乳腺干细胞和祖细胞谱系的假定标记
  • 批准号:
    7082282
  • 财政年份:
    2006
  • 资助金额:
    $ 29.93万
  • 项目类别:
Mechanisms of Death and Survival in Oligodendroglia
少突胶质细胞的死亡和生存机制
  • 批准号:
    7628361
  • 财政年份:
    2005
  • 资助金额:
    $ 29.93万
  • 项目类别:
Mechanisms of Death and Survival in Oligodendroglia
少突胶质细胞的死亡和生存机制
  • 批准号:
    7450794
  • 财政年份:
    2005
  • 资助金额:
    $ 29.93万
  • 项目类别:
Mechanisms of Death and Survival in Oligodendroglia
少突胶质细胞的死亡和生存机制
  • 批准号:
    7254073
  • 财政年份:
    2005
  • 资助金额:
    $ 29.93万
  • 项目类别:

相似海外基金

Gain-of-function toxicity in alpha-1 antitrypsin deficient type 2 alveolar epithelial cells
α-1 抗胰蛋白酶缺陷型 2 型肺泡上皮细胞的功能获得毒性
  • 批准号:
    10751760
  • 财政年份:
    2024
  • 资助金额:
    $ 29.93万
  • 项目类别:
The role of alveolar macrophages and regulatory pathways in post-transplant lung inflammation.
肺泡巨噬细胞和调节途径在移植后肺部炎症中的作用。
  • 批准号:
    23K08315
  • 财政年份:
    2023
  • 资助金额:
    $ 29.93万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanical signaling through the nuclear membrane in lung alveolar health
通过核膜的机械信号传导影响肺泡健康
  • 批准号:
    10677169
  • 财政年份:
    2023
  • 资助金额:
    $ 29.93万
  • 项目类别:
Mechanistic studies of the genetic contribution of desmoplakin to pulmonary fibrosis in alveolar type 2 cells
桥粒斑蛋白对肺泡2型细胞肺纤维化的遗传贡献机制研究
  • 批准号:
    10736228
  • 财政年份:
    2023
  • 资助金额:
    $ 29.93万
  • 项目类别:
Pilot Studies of PAX3-FOXO1 Fusions Proteins in Alveolar Rhabdomyosarcoma
PAX3-FOXO1 融合蛋白在肺泡横纹肌肉瘤中的初步研究
  • 批准号:
    10726763
  • 财政年份:
    2023
  • 资助金额:
    $ 29.93万
  • 项目类别:
Novel alveolar mechanisms of hypoxemia in hepatopulmonary syndrome
肝肺综合征低氧血症的新肺泡机制
  • 批准号:
    10718446
  • 财政年份:
    2023
  • 资助金额:
    $ 29.93万
  • 项目类别:
Utilizing induced pluripotent stem cells to study the role of alveolar type 2 cell dysfunction in pulmonary fibrosis
利用诱导多能干细胞研究肺泡2型细胞功能障碍在肺纤维化中的作用
  • 批准号:
    10591174
  • 财政年份:
    2023
  • 资助金额:
    $ 29.93万
  • 项目类别:
Injury of blood brain and alveolar-endothelial barriers caused by alcohol and electronic cigarettes via purinergic receptor signaling
酒精和电子烟通过嘌呤受体信号传导引起血脑和肺泡内皮屏障损伤
  • 批准号:
    10638221
  • 财政年份:
    2023
  • 资助金额:
    $ 29.93万
  • 项目类别:
Alveolar Epithelial Cell Dysfunction Induced By Flavored E-Cigarette Aerosols
加味电子烟气雾剂引起的肺泡上皮细胞功能障碍
  • 批准号:
    10770080
  • 财政年份:
    2023
  • 资助金额:
    $ 29.93万
  • 项目类别:
Delineating the role of let-7 microRNA on lung AT2 cell homeostasis, alveolar regeneration, and interstitial lung disease
描述let-7 microRNA对肺AT2细胞稳态、肺泡再生和间质性肺疾病的作用
  • 批准号:
    10634881
  • 财政年份:
    2023
  • 资助金额:
    $ 29.93万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了